Our 2021 Florida State of Reform Health Policy Conference Detailed Agenda is a list of over 60 speakers and experts from across the spectrum of care.
The agenda and speaker list are driven by input from our Convening Panel of leaders in Florida health care and we’re looking forward to a great event on May 20th. If you’re not already registered, you can do so here.
The heading colors correspond to track colors on our Topical Agenda to help you organize your day.
For now, let us know if you have any questions about the conference. We look forward to seeing you!
Please note, all session times are in EDT.
9:00 - 9:15
Welcome & Introductions
DJ Wilson, Host of State of Reform, will kick off the day with comments framing the conference agenda, and the role of State of Reform hopes to play in this challenging era of health policy and politics. He will orient us to the conference, including a run down of how best to utilize the unique tools of the virtual platform.
DJ Wilson: Host, State of Reform
9:15 - 9:50
Morning Keynote: Future of COVID in Florida and the US
Chris Murray, MD, leads the Institute for Health Metrics and Evaluation. In that role, he oversees modeling related to Covid and other diseases, work that has been proven to be among the most accurate predictors of COVID activity in the United States. Dr. Murray will share the latest data and an up-to-date model of COVID for the summer and fall of 2021. Want to know when we will get herd immunity in the US? Dr. Murray knows, and will speak to this question to kick off State of Reform.
Christopher Murray, MD: Director, Institute for Health Metrics and Evaluation
10:00 - 10:50
Capitol insiders review the 2021 session
These government relations professionals will discuss state health policy, look back on the 2021 session, and talk through how they see the interim work playing out over the course of 2021. Bring your questions, as well as your own insights, to a session that is particularly interactive and forward thinking.
Barney Bishop III: President and Chief Executive Officer, Barney Bishop Consulting
David Poole: Director, Legislative Affairs, AIDS Healthcare Foundation
Toby Philpot: Chief Lobbyist, Florida Health Care Association
10:00 - 10:50
The changing nature of plan-provider relations
The relationship between the plan which pays for care and the provider which delivers it remains the single most important relationship in all of health care. So, how has the pandemic changed the nature of that relationship? This panel will highlight the conversations taking place and the outcomes as a result of the last year of working together.
Nancy Pealing: Chief Quality Officer, ConsejoSano
Michael Lawton: President, United Healthcare
Steve Harris: Vice President of Payor & Government Affairs, Tampa General Hospital
Gustavo Leon: Regional Vice President, Provider Solutions, Simply Healthcare
10:00 - 10:50
The emerging impacts of climate change on health
There is increasing awareness that the changing climate is impacting the health of our communities in new and somewhat novel ways. But, what does that look like? How does this move from the theoretical to the real? And, how can health care respond? This session will explore what we know and what we are learning about the impacts to our health from a changing climate at both a population and individual level.
Patrick Breysse: Director, National Center for Environmental Health, Centers for Disease Control & Prevention
J. Glenn Morris, MD: Director, Emerging Pathogens Institute, University of Florida
Todd Sack, MD: Board Member, Florida Physicians for Social Responsibility
10:00 - 10:50
Integration of the social determinants into a system of care
We know the social determinants are primary drivers of one's health status. But, putting that awareness to use in a sustainable way that improves health is no easy task. Moreover, integrating that into a broader system of care takes both system transformation and individual provider effort. This session of experts will talk through the new efforts to address SDOH and what is being learned through that work.
Kevin Clark: Business Development Manager, 3M
Jeff Patmont: Business Development, Pathway Home Solutions
Don Axelrad, PhD: Associate Professor, Florida A&M University
Policy leadership: Democrats
This panel of Democratic legislators will talk through the highs and lows of the legislative session and offer their thoughts on the work ahead for Florida health policy. Plan on good back and forth, where audience members are encouraged to offer both questions and insights in this session.
Sen. Shevrin D. Jones: Member, Senate Committee on Health Policy
Rep. Kamia Brown: Ranking Member, Health Care Appropriations Subcommittee
Rep. Dotie Joseph: Ranking Member, House Finance and Facilities Subcommittee
Catalyzing the move to value based care
The move to value based care has been more than a decade in the making. Yet Florida's health care system shows wide variation in health care performance based on quality and outcomes. So, this session will explore what has been working in Florida for value-based care and where there are still obstacles to moving this vision forward.
Elizabeth Miller: Chief Executive Officer, Sunshine Health
Mary Mayhew: Chief Executive Officer, Florida Hospital Association
Nicole Bradberry: Chief Executive Officer, Florida Association of ACO's
Ray Parzik: Senior Director, Value Based Contracts, Florida Blue
Measuring the public's trust in the health care system
The complexity of our health care system, matched with the stubborn variation in outcomes and sometimes hard to justify pricing, has worked to erode the publics trust in our health care system. This panel of thought leaders will talk through data, experience and issues that can erode this trust, and what might be done to address it.
Dennis Saver, MD: Regional Bio-Ethics Director, Cleveland Clinic Indian River Hospital
Jodi Ray: Program Director of Florida Covering Kids & Families, USF Health
Michelle Turner: Head of Talent and Partnerships, Hazel Health
Addressing the stark variation in health equity
From vaccine distribution to access to health care services, there continues to be variation in health outcomes based on race, gender, and economic status. So, what are the moral implications of this difficult reality? How can our system do better by our neighbors and community members? Be prepared to engage in a dynamic discussion on how we as a health care community can do better.
Rep. Nicholas Duran: Member, Health & Human Services Committee
Abner Mason: Chief Executive Officer, ConsejoSano
Janisse Schoepp, PhD: Vice President, Operations and Strategy, Health Foundation of South Florida
Alison Yager: Executive Director, Florida Health Justice Project
12:00 - 12:50
Policy leadership: Republicans
This panel of some of Florida's most thoughtful and impactful Republican legislators will review the work of the legislative session. They will talk through the work accomplished, the work which remains, and what to expect in 2021. Bring your questions to what is always an interactive conversation.
Sen. Manny Diaz, Jr: Chair, Committee on Health Policy
Rep. Mike Beltran: Member, House Finance and Facilities Subcommittee
Rep. Tom Fabricio: Member, House Finance and Facilities Subcommittee
12:00 - 12:50
An honest conversation about cost drivers
Of cost, quality, and access, it would appear that less has been done to substantively address system-level cost issues than the other areas. Doing so requires some level of candor, of course. So, this panel will bring their insights and their honest approach to what promises to be a lively discussion focused on a common interest to bend the cost curve of health care.
Audrey Brown: President & Chief Executive Officer, Florida Association of Health Plans
Michael Garner: Chief Executive Officer, The Garner Group
Jennifer Jackman: Vice President, Business Development, America's Physician Groups
12:00 - 12:50
Meeting the complex needs of Florida's dual eligible population
The Centers for Medicare and Medicaid Services (CMS) has authorized several care management approaches to coordinate benefits for recipients dually enrolled in the Medicare and Medicaid programs. During this session, panelists will discuss opportunities for health plans serving the dual eligible population. Panelists will share their perspective on the impact of federal policy and various market features on Medicare Advantage plans and other plans, and providers serving duals.
Mary Hsieh, PharmD: Managing Director, Medicare and Duals, Health Management Associates
Lee Bowers: Senior Vice President, Medicare Florida, WellCare (Sunshine Health)
James Henderson: Chief Innovation Officer, Independent Living Systems
12:00 - 12:50
The impact of COVID on behavioral health
The impacts of the pandemic are likely to continue to impact our behavior for years to come. From increased substance use to anxiety about social settings, many Floridians will face a difficult path to a "new normal." This panel will discuss what that road might look like for both individuals and communities, as well as the policy responses that can support recovery.
Melanie Brown Woofter: President & Chief Executive Officer, Florida Behavioral Health Association
Gayle Giese: President, Florida Mental Health Advocacy Coalition
Hanifa Jones, MD: Chief Medical Officer, Mind 24-7
1:00 - 1:50
Update on federal health policy
With a new federal administration, and health care reform primed as a key issue in the 117th Congress, this session will hear from policy advocates and government relations professionals that are at work trying to shape the next wave of federal policy making in 2021. Bring your questions to get a better understanding of what is to come from both Congress and the Biden administration.
Paul Dioguardi: Senior Vice President, Forbes Tate
Larissa Martin: Partner, 50 State
Scott Nelson: Partner, K&L Gates
1:00 - 1:50
Innovations in telehealth from the pandemic
The success of telehealth this last year is clear. While most seem to agree that some version of telehealth is here to stay, we still need state and federal health policy to support continued innovation. These panelists will draw upon their own experiences and the conversations in the space to highlight the challenges and opportunities on the road ahead.
Holly Prince: President, Simply Healthcare
Andrew Behrman: President & Chief Executive Officer, Florida Association of Community Health Centers
Jeff Gelblum: Board Member, First Choice Neurology
1:00 - 1:50
Transparency, pricing and purchasing strategies of prescription drugs
Prescription drug pricing and purchasing has been a major topic in both policy and market-centered conversations. So, where do we stand on the other side of a big session on the subject? How has COVID changed the perception or importance of pharmacies and pharma? This panel will explore these topics and discuss your questions.
Michael Jackson: Executive Vice President & Chief Executive Officer, Florida Pharmacy Association
Eric Kimmelblatt: Senior Director, Managed Markets, Artia Solutions
Shane Abbott, PharmD: Co-Owner, The Prescription Place
2:00 - 2:50
Keynote: Health Policy and the next 100 days of the Biden administration
Jim Capretta is the Milton Friedman Chair at the American Enterprise Institute, one of the country's most prominent free market-centered think tanks and voices for market-based reforms. Capretta's work on health reform is substantive, meaningful, and draws respect from both sides of the asile. He served in the administration of President George W. Bush in the Office of Management and Budget, and has tracked federal and state health spending closely throughout his career. His keynote will provide attendees with a review of President Biden's first 100 days of health policy and look ahead to what we might expect from the next 100 days to come.
Jim Capretta: Milton Friedman Chair, American Enterprise Institute